WST Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeP/E ratio43.26Forward 38.31
EPS (TTM)$7.4856.1% YoY
Profit margin16.9%HEALTHCARE
Market cap$22.86BLarge cap
Wall Street coverage
$358.79median target· current $328.64 (+9.2%)15 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Valuation
- Forward P/E
- 38.31
- PEG ratio
- 3.17
- P/B
- 7.79
- P/S (TTM)
- 7.10
- EV/EBITDA
- 27.18
Profitability & growth
- ROE (TTM)
- 19.1%
- Operating margin
- 21.7%
- Revenue growth YoY
- 21.0%
- Dividend yield
- 0.3%
- Beta
- 1.18
Last earnings
Apr 23, 2026 · Estimate $1.68 · Reported $2.13
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
33 articles · sorted by datePage 1 of 2 · 33 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About West Pharmaceutical Services Inc
Company profileWest Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania.
Classification
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 530 HERMAN O. WEST DRIVE, EXTON, PA
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$22.86B
Shares outstanding$70.6M
52W high$336.82
52W low$206.12
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent